Trials / Completed
CompletedNCT05103995
Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation
Impact of Donor-recipient ABO Matching on Patients' Outcome After Peripheral Blood Stem Cell Haploidentical Stem Cell Transplantation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 510 (actual)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 15 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
the impact of donor-recipient ABO matching on outcome of peripheral blood stem cell haploidentical hematopoietic stem cell transplantation
Detailed description
The impact of donor-recipient ABO compatibility on transplant outcomes had been evaluated in different transplant settings, but had shown different results. The investigators set out to investigate the impact of ABO incompatibility on post-transplant outcomes, engraftment kinetics and blood product requirements, transfusion independence, the incidence of poor graft function (PGF) in anti-T-lymphocyte globulin (ATG) based haplo-SCT with PBSC grafts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | no intervention, just observation |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2019-03-31
- Completion
- 2021-10-01
- First posted
- 2021-11-02
- Last updated
- 2021-11-02
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05103995. Inclusion in this directory is not an endorsement.